De novo human T-cell leukemia virus type 1 infection of human lymphocytes in NOD-SCID, common gamma-chain knockout mice
- PMID: 16943297
- PMCID: PMC1641804
- DOI: 10.1128/JVI.01009-06
De novo human T-cell leukemia virus type 1 infection of human lymphocytes in NOD-SCID, common gamma-chain knockout mice
Abstract
Human T-cell leukemia virus type 1 (HTLV-1) is the etiologic agent of adult T-cell leukemia, a disease that is triggered after a long latency period. HTLV-1 is known to spread through cell-to-cell contact. In an attempt to study the events in early stages of HTLV-1 infection, we inoculated uninfected human peripheral blood mononuclear cells and the HTLV-1-producing cell line MT-2 into NOD-SCID, common gamma-chain knockout mice (human PBMC-NOG mice). HTLV-1 infection was confirmed with the detection of proviral DNA in recovered samples. Both CD4+ and CD8+ T cells were found to harbor the provirus, although the latter population harbored provirus to a lesser extent. Proviral loads increased with time, and inverse PCR analysis revealed the oligoclonal proliferation of infected cells. Although tax gene transcription was suppressed in human PBMC-NOG mice, it increased after in vitro culture. This is similar to the phenotype of HTLV-1-infected cells isolated from HTLV-1 carriers. Furthermore, the reverse transcriptase inhibitors azidothymidine and tenofovir blocked primary infection in human PBMC-NOG mice. However, when tenofovir was administered 1 week after infection, the proviral loads did not differ from those of untreated mice, indicating that after initial infection, clonal proliferation of infected cells was predominant over de novo infection of previously uninfected cells. In this study, we demonstrated that the human PBMC-NOG mouse model should be a useful tool in studying the early stages of primary HTLV-1 infection.
Figures
Similar articles
-
Engraftment of peripheral blood mononuclear cells from human T-lymphotropic virus type 1 carriers in NOD/SCID/gammac(null) (NOG) mice.Int J Cancer. 2007 Nov 15;121(10):2205-11. doi: 10.1002/ijc.22972. Int J Cancer. 2007. PMID: 17657714
-
Multiple integrations of human T-lymphotropic virus type 1 proviruses in the engrafted cells from the asymptomatic carriers in NOD/SCID/gammacnull mice.Intervirology. 2010;53(4):229-39. doi: 10.1159/000302760. Epub 2010 Mar 30. Intervirology. 2010. PMID: 20357492
-
In vivo cellular tropism of human T-lymphotropic virus type II is not restricted to CD8+ cells.Virology. 1995 Jul 10;210(2):441-7. doi: 10.1006/viro.1995.1360. Virology. 1995. PMID: 7542419
-
Human T cell leukemia virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation.J Cell Physiol. 2002 Feb;190(2):133-59. doi: 10.1002/jcp.10053. J Cell Physiol. 2002. PMID: 11807819 Review.
-
Human T cell leukemia virus type I (HTLV-I) and human diseases.Annu Rev Immunol. 1997;15:15-37. doi: 10.1146/annurev.immunol.15.1.15. Annu Rev Immunol. 1997. PMID: 9143680 Review.
Cited by
-
The neutralizing function of the anti-HTLV-1 antibody is essential in preventing in vivo transmission of HTLV-1 to human T cells in NOD-SCID/γcnull (NOG) mice.Retrovirology. 2014 Aug 28;11:74. doi: 10.1186/s12977-014-0074-z. Retrovirology. 2014. PMID: 25163482 Free PMC article.
-
Molecular Studies of HTLV-1 Replication: An Update.Viruses. 2016 Jan 27;8(2):31. doi: 10.3390/v8020031. Viruses. 2016. PMID: 26828513 Free PMC article. Review.
-
Animals Models of Human T Cell Leukemia Virus Type I Leukemogenesis.ILAR J. 2016;57(1):3-11. doi: 10.1093/ilar/ilv045. ILAR J. 2016. PMID: 27034390 Free PMC article.
-
Comprehensive in vitro analysis of simian retrovirus type 4 susceptibility to antiretroviral agents.J Virol. 2013 Apr;87(8):4322-9. doi: 10.1128/JVI.03208-12. Epub 2013 Jan 30. J Virol. 2013. PMID: 23365453 Free PMC article.
-
The Past, Present, and Future of a Human T-Cell Leukemia Virus Type 1 Vaccine.Front Microbiol. 2022 May 4;13:897346. doi: 10.3389/fmicb.2022.897346. eCollection 2022. Front Microbiol. 2022. PMID: 35602078 Free PMC article. Review.
References
-
- Akagi, T., I. Takeda, T. Oka, Y. Ohtsuki, S. Yano, and I. Miyoshi. 1985. Experimental infection of rabbits with human T-cell leukemia virus type I. Jpn. J. Cancer Res. 76:86-94. - PubMed
-
- Bangham, C. R., and M. Osame. 2005. Cellular immune response to HTLV-1. Oncogene 24:6035-6046. - PubMed
-
- Collins, N. D., G. C. Newbound, B. Albrecht, J. L. Beard, L. Ratner, and M. D. Lairmore. 1998. Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo. Blood 91:4701-4707. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials